Literature DB >> 17507542

Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Audun Aase1, Tove Karin Herstad, Samuel Merino, Kari Torkildsen Brandsdal, Bjørn Peter Berdal, Erja M Aleksandersen, Ingeborg S Aaberge.   

Abstract

Bordetella pertussis is the causative agent of pertussis (whooping cough). Despite high vaccination coverage, pertussis remains a significant disease in many countries. Besides vaccination, transient carriage of Bordetella spp. or other cross-reacting organisms adds to the immunity against pertussis. However, the various immunological mechanisms conferring protection remain largely unknown. In this study, paired serum samples from 464 healthy Norwegian military recruits were collected, the first at enrolment and the second about 8 months later. The prevalence of pertussis during military service was examined by comparing the paired serum samples for immunoglobulin G (IgG) antibodies against pertussis toxin (PT) by enzyme-linked immunosorbent assay (ELISA). Seventy-eight percent of the recruits had low levels of IgG antibodies against PT in both samples. Conversely, 8.4% of the recruits demonstrated high anti-PT IgG levels in the first sample, indicative of recent pertussis prior to enrolment. One recruit experienced seroconversion, indicating pertussis during service. A subset of 248 serum samples with low, medium, and high anti-PT IgG titers were analyzed by a different ELISA kit for IgG and IgA antibodies against PT and filamentous hemagglutinin (FHA) and for opsonophagocytic activity (OPA), for induction of C3b deposition products, and for IgG binding with live B. pertussis as the antigen. We observed high correlations between OPA and IgG against live bacteria (r = 0.83), between OPA and IgG anti-FHA (r = 0.79), between OPA and anti-PT IgG (r = 0.68), and between OPA and C3b binding (r = 0.70) (P < 0.0001 for all). Anti-PT IgA did not correlate closely with the other assays.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507542      PMCID: PMC1951054          DOI: 10.1128/CVI.00081-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  44 in total

1.  Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation.

Authors:  J M Vincent; J D Cherry; W F Nauschuetz; A Lipton; C M Ono; C N Costello; L K Sakaguchi; G Hsue; L A Jackson; R Tachdjian; P A Cotter; J A Gornbein
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

Authors:  D H Lenz; C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; P S Mobberley-Schuman; E L Hewlett; M C Gray; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Fc receptor-mediated immunity against Bordetella pertussis.

Authors:  M E Rodriguez; S M Hellwig; D F Hozbor; J Leusen; W L van der Pol; J G van de Winkel
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 6.  How to make sense of pertussis immunogenicity data.

Authors:  P Olin; H O Hallander; L Gustafsson; E Reizenstein; J Storsaeter
Journal:  Clin Infect Dis       Date:  2001-12-15       Impact factor: 9.079

7.  Growth phase influences complement resistance of Bordetella pertussis.

Authors:  Michael G Barnes; Alison A Weiss
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

8.  Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.

Authors:  S L Hodder; J D Cherry; E A Mortimer; A B Ford; J Gornbein; K Papp
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

9.  Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.

Authors:  L M Schaeffer; A A Weiss
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

10.  Characterization of environmental regulators of Bordetella pertussis.

Authors:  A R Melton; A A Weiss
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more
  9 in total

1.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

2.  Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.

Authors:  Jenny Herbert; Stephen Thomas; Charlotte Brookes; Claudia Turner; Paul Turner; Francois Nosten; Kirsty Le Doare; Michael Hudson; Paul T Heath; Andrew Gorringe; Stephen Taylor
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

3.  Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma.

Authors:  Frances Alexander; Emily Brunt; Holly Humphries; Breeze Cavell; Stephanie Leung; Lauren Allen; Rachel Halkerston; Elodie Lesne; Elizabeth Penn; Stephen Thomas; Andrew Gorringe; Stephen Taylor
Journal:  Methods Mol Biol       Date:  2022

Review 4.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

5.  Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection.

Authors:  Saskia van der Lee; Susanne P Stoof; Mariette B van Ravenhorst; Pieter G M van Gageldonk; Nicoline A T van der Maas; Elisabeth A M Sanders; Anne-Marie Buisman; Guy A M Berbers
Journal:  Euro Surveill       Date:  2017-11

6.  Bordetella pertussis isolates vary in their interactions with human complement components.

Authors:  Charlotte Brookes; Irene Freire-Martin; Breeze Cavell; Frances Alexander; Stephen Taylor; Ruby Persaud; Norman Fry; Andrew Preston; Dimitri Diavatopoulos; Andrew Gorringe
Journal:  Emerg Microbes Infect       Date:  2018-05-09       Impact factor: 7.163

7.  Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients.

Authors:  Elise S Hovingh; Betsy Kuipers; Axel A Bonačić Marinović; Hendrik Jan Hamstra; Danielle Hijdra; Lapo Mughini Gras; Inonge van Twillert; Ilse Jongerius; Cecile A C M van Els; Elena Pinelli
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

8.  Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking.

Authors:  Edith Acquaye-Seedah; Yimin Huang; Jamie N Sutherland; Andrea M DiVenere; Jennifer A Maynard
Journal:  Cell Microbiol       Date:  2018-09-23       Impact factor: 3.715

Review 9.  Evaluation of Anti-PT Antibody Response after Pertussis Vaccination and Infection: The Importance of Both Quantity and Quality.

Authors:  Alex-Mikael Barkoff; Aapo Knuutila; Jussi Mertsola; Qiushui He
Journal:  Toxins (Basel)       Date:  2021-07-21       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.